Analysts at Zacks have given a hold rating on Neogenomics Inc (NASDAQ:NEO) with a rank of 3. The counter has received an average rating of 1 from 5 brokerage firms. 5 analysts have rated the company as a strong buy. Neogenomics Inc (NASDAQ:NEO) ended the most recent trading session with positive gains. The shares of the Neogenomics Inc (NASDAQ:NEO), which opened the session at $4.12, peaked out after touching $4.38 and closed the day with a gain of 1.91% or 0.08 points at $4.27. The bulls had to fight hard to eke out gains as some serious selling pressure caused a price nosedive pushing the price towards $4.1, which was the days low. At close, the volume was recorded at 243,928 shares. The market cap of the company stands at $256 million and the number of shares outstanding is 59,972,000.

Research firm Zacks has rated Grupo Financiero Galicia S.A. (NASDAQ:GGAL) and has ranked it at 3, indicating that its shares are a hold. 2 Wall Street analysts have given the company an average rating of 2. The counter has received a hold rating based on the suggestion from 1 analysts in latest recommendations. Strong buy was given by 1 Wall Street Analysts. Grupo Financiero Galicia S.A. (NASDAQ:GGAL) faced a 1.33% cut in its share price in the most recent trading session. Bearish sentiments were clearly visible in the counter as the shares, which had opened at $15.86, failed to make any significant gains due to the relentless selling pressure, which saw the share price drop to $15.35. The last trade was registered at $15.56, down 0.21 points, and the volume was measured at 243,902 shares. The shares had closed the previous day trading session at $15.77. The company has a market cap of $1,586 million and the 52-week high of the share price is $18.5.

Comments

Leave a Reply

You must be logged in to post a comment.